Current Headlines

  1. ProMetic Seeks Orphan Status For Lead IPF Drug
    10/20/2014

    Biopharmaceutical company ProMetic Life Sciences announced its intent to pursue idiopathic pulmonary fibrosis (IPF) as an orphan indication for its lead drug candidate PBI-4050.

  2. New Multiple Myeloma Drug To Enter Clinical Trials
    10/20/2014

    Researchers at the Imperial College London have developed a new type of drug for treating multiple myeloma which will enter clinical trials in late 2015.

  3. Pall ForteBio Introduces Off-The-Shelf Dip And Read Anti-CHO HCP Detection Kit To Accelerate Drug Development
    10/20/2014

    Pall ForteBio LLC, a division of Pall Corp. and a leading supplier of instrumentation and analytics for accelerated drug discovery and development, has announced commercial availability of a new Dip and Read™ Anti-CHO (Chinese hamster ovary) Host Cell Protein (HCP) Detection Kit for quantitation of residual HCPs.

  4. SSB’s Production Facility Design For WuXi AppTec Receives Honorable Mention At The ISPE Facility Of The Year Awards 2014
    10/20/2014

    The WuXi AppTec bulk cell culture production facility designed by Sartorius Stedim Biotech (SSB), a leading international supplier of pharmaceutical and biotech equipment, received an honorable mention in the 2014 Facility of the Year Awards.

  5. Alzheimer's Research Breakthrough Could Accelerate Development Of New Treatments
    10/20/2014

    Scientists at Massachusetts General Hospital (MGH) have developed an ‘Alzheimer's-in-a-dish’ breakthrough, which will allow them to replace the current poorly performing animal models with an innovative laboratory culture system for studying Alzheimer's disease and discovering new treatments.

  6. Sonoco ThermoSafe Survey Reveals Future Needs, Trends Of Cold Chain Industry
    10/20/2014

    Sonoco ThermoSafe, a unit of Sonoco and a leading global provider of temperature assurance packaging, revealed the results of its survey entitled “Assessing the Future of the Cold Chain Industry” at the 12th annual Cold Chain Global Forum in Boston on Oct. 9, 2014.

  7. Sanofi Ally Shantha Begins Rotavirus Vaccine Phase 3 Trial
    10/17/2014

    Sanofi’s vaccine division, Sanofi Pasteur, reported that its affiliate Shantha Biotechnics has initiated the Phase 3 clinical trial in India for its investigational vaccine for rotavirus.

  8. Pfenex, PATH Link Arms For Vaccine Development Model
    10/17/2014

    Clinical stage biotech Pfenex announced that it has partnered with international nonprofit organization PATH in a multi-product research initiative to improve vaccine production.

  9. Auspherix, Domainex Join Forces Against Drug-Resistant Infections
    10/17/2014

    Early-stage anti-infectives firm Auspherix and U.K.-based drug discovery services firm Domainex announced a new collaboration to develop treatments that will combat antibiotic-resistant bacterial infections.

  10. Rich Pharmaceuticals Acquires Phorbol Esters For Hodgkin's Lymphoma
    10/17/2014

    Rich Pharmaceuticals has acquired the patents, intellectual property, and commercialization rights for phorbol esters in the treatment of Hodgkin's lymphoma.

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.